Terapia asistida por robot para miembros superiores en pacientes con síndrome de Guillain-Barré (RAUL-Project)
Efectos de la terapia asistida por robot para la recuperación funcional de las extremidades superiores en pacientes con síndrome de Guillain-Barré: un ensayo controlado aleatorio
Guillain-Barré Syndrome is an immune-mediated polyradiculoneuropathy, with around 100,000 new cases reported worldwide annually.
The aim of this double-blind randomized controlled trial with a SHAM control group is to evaluate the effects of robot-assisted therapy, integrated with conventional therapy, on upper limb motor recovery in patients with GBS.
Descripción general del estudio
Estado
Estado
Condiciones
Condiciones
Intervención / Tratamiento
Intervención / Tratamiento
Descripción detallada
Guillain-Barré Syndrome is a leading cause of acute flaccid paralysis, presenting with limb weakness and hyporeflexia or areflexia. Guillain-Barré Syndrome is an immune-mediated polyradiculoneuropathy, with around 100,000 new cases reported worldwide annually. This study aims to assess the effectiveness of a robot-assisted rehabilitation treatment for upper limb motor recovery in patients with Guillain-Barré Syndrome. A double-blind randomized trial will be conducted, where the experimental group will undergo actual robotic rehabilitation sessions, while the control group will perform sessions in which the robot will carry out simple mobilization, comparable to traditional interventions. This approach will help maintain participant blinding. Patients will be evaluated before and after treatment, and with two follow-up assessments 60 and 90 days after therapy initiation. Evaluations will include muscle recruitment and autonomy in daily living activities.
Tipo de estudio
Tipo de estudio
Inscripción (Estimado)
Inscripción
Fase
Fase
- Fase 4
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Lazio
-
Rome, Lazio, Italia, 00179
- IRCCS Santa Lucia Foundation
-
-
Criterios de participación
Criterio de elegibilidad
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Diagnosis of Guillan-Barré Syndrome;
- UL motor impairment (0-4 in the Medical Research Council scale);
- sub-acute phase (until 180 days);
- Patients able to maintain the sitting position.
Exclusion Criteria:
- Concomitant neurological, orthopedic, metabolic, and oncological diseases;
- Cognitive impairment assessed with the Mini Mental State Examination (score under 24 points);
- Visual deficit;
- Hearing disorders.
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Doble
Número de brazos
Armas e Intervenciones
Grupo de participantes/brazoGrupo de participantes/brazo |
Intervención / TratamientoIntervención / Tratamiento |
|---|---|
|
Experimental: Active-assisted therapy with an upper limb robotic exoskeleton
Patients will receive upper limb neurorehabilitation training using a robotic exoskeleton administered by the therapist. The assistance provided by the device is adjusted based on the maximum force (as a percentage of the upper limb's weight) the robot needs to exert to assist the patient's movements. The computer-robot interface is designed to offer various exergames that require specific upper limb movements. All movements performed by the patient using the exoskeleton will provide immediate audiovisual feedback on the computer screen. The training will consist of 20 sessions, with five 45-minute sessions per week. |
Patients will undergo 20 session of 45 minutes each with an exoskeleton for upper limb rehabilitation. The assistance provided by the device is adjusted based on the maximum force (as a percentage of the upper limb's weight) the robot needs to exert to assist the patient's movements. Each session will include exercises designed to improve the range of motion (ROM) of the shoulder, elbow, wrist, and enhance hand coordination. The training parameters, such as difficulty level, duration, and visual stimuli, will be adjusted based on the patient's residual abilities. The selected exercises may involve movements of a single joint along one axis, combined movements of a single joint around 2 or 3 axes, selective exercises for the opening and closing hand, or multi-joint exercises. All exercises will be realized with audiovisual feedback. |
|
Comparador activo: Passive mobilization with an upper limb robotic exoskeleton
Patients will undergo a neurorehabilitation intervention with a SHAM treatment under the guidance of the experimental therapist. |
Patients will undergo 20 session of 45 minute of a neurorehabilitation intervention with a SHAM treatment under the guidance of the experimental therapist. This will involve passive mobilization using the exoskeleton for the upper limb, without any audiovisual feedback. They will not realize any active movement during the training. |
¿Qué mide el estudio?
Medidas de resultado primarias
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Fugl-Meyer Assessment scale for Upper Extremity (FMAUE)
Periodo de tiempo: Baseline (t0); 30 days (t1); 60 days (t2); 90 days (t3).
|
THE FMAUE will be used to assess the change in the motor and sensory functions of the upper limb. The FMAUE included five domains: motor functioning, sensitivity, coordination, range of motion and pain. The score ranging from 0 to 66 points, a higher score corresponds to a better function of the upper limb. |
Baseline (t0); 30 days (t1); 60 days (t2); 90 days (t3).
|
Medidas de resultado secundarias
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
The 36-Item Short-Form Health Survey (SF-36)
Periodo de tiempo: Baseline (t0); 30 days (t1); 60 days (t2); 90 days (t3).
|
The SF-36 will be used to assess the change in health-related quality of life. The SF-36 is organized into 8 different domains that are divided into physical components (Physical functioning, limitations due to physical problems, bodily pain and general perceptions of health status) and mental components (Social functioning, general mental health, limitations due to emotional problems and vitality). Each of the 8 domain scores, added together, is linearly transformed on a scale from 0 to 100, where 0 equals negative health and 100 equals positive health. |
Baseline (t0); 30 days (t1); 60 days (t2); 90 days (t3).
|
|
modified Barthel Index (mBI)
Periodo de tiempo: Baseline (t0); 30 days (t1); 60 days (t2); 90 days (t3).
|
The mBI will be used to assess the change in the autonomy of patients during their activities of daily living. This scale has a score ranging from 0 to 100 points, a higher score corresponds to a better performance in the activities of daily living. |
Baseline (t0); 30 days (t1); 60 days (t2); 90 days (t3).
|
|
ABILHAND
Periodo de tiempo: Baseline (t0); 30 days (t1); 60 days (t2); 90 days (t3).
|
The ABILHAND will be used to assess manual dexterity. The ABILHAND is a questionnaire-based assessment tool that measures the difficulty a patient perceives in using their hands to perform manual operations and activities in daily living. It assesses upper limb functionality. It has nonlinear logit values ranging from 1.72 to -2.18. |
Baseline (t0); 30 days (t1); 60 days (t2); 90 days (t3).
|
|
The Medical Research Council scale (MRC)
Periodo de tiempo: Baseline (t0); 30 days (t1); 60 days (t2); 90 days (t3).
|
The MRC will be used to assess muscle strength. The score ranges from 0 to 5 where 0 equals no muscle recruitment and 5 normal muscle force. |
Baseline (t0); 30 days (t1); 60 days (t2); 90 days (t3).
|
|
The nine hole peg test (NHPG).
Periodo de tiempo: Baseline (t0); 30 days (t1); 60 days (t2); 90 days (t3).
|
The NHPG will be used to assess fine manual dexterity. The NHPT consists of a square board with 9 pegs. At one end of the board are holes to insert the pegs, and at the other end is a shallow round plate to store the extracted pegs. The NHPT is administered by asking the patient to take the pegs from a container, one by one, and insert them into the holes on the board, as quickly as possible. |
Baseline (t0); 30 days (t1); 60 days (t2); 90 days (t3).
|
|
Grip strength
Periodo de tiempo: Baseline (t0); 30 days (t1); 60 days (t2); 90 days (t3).
|
Grip strength will be assessed using a manual digital dynamometer. The maximum strength of the whole hand will be recorded for three times without feedback (with the patient sitting with his back to the monitor). |
Baseline (t0); 30 days (t1); 60 days (t2); 90 days (t3).
|
Otras medidas de resultado
Otras medidas de resultado
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Mini-Mental State Examination (MMSE)
Periodo de tiempo: T0 (Baseline)
|
MMSE is a widely used psychometric tool in clinical settings to assess cognitive function. It is employed to detect cognitive impairments, monitor the progression of neurodegenerative diseases such as Alzheimer disease, and evaluate the severity of cognitive decline. The test consists of a series of questions and tasks that assess various cognitive domains, including orientation in time and space, memory, attention, language, and the ability to follow simple commands. |
T0 (Baseline)
|
Colaboradores e Investigadores
Patrocinador
Patrocinador
Investigadores
Investigadores
- Silla de estudio: Alex Martino Cinnera, PhD, IRCCS Santa Lucia Foundation
- Silla de estudio: Diego Piatti, BSc, IRCCS Santa Lucia Foundation
- Director de estudio: Laura Casagrande Conti, MSc, IRCCS Santa Lucia Foundation
- Director de estudio: Martina D Arienzo, BSc, IRCCS Santa Lucia Foundation
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Inicio del estudio
Finalización primaria (Estimado)
Finalización primaria
Finalización del estudio (Estimado)
Finalización del estudio
Fechas de registro del estudio
Enviado por primera vez
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Publicado por primera vez
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización publicada
Última actualización enviada que cumplió con los criterios de control de calidad
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
- Trastornos posinfecciosos
- Enfermedades del Sistema Nervioso
- Procesos Patológicos
- Enfermedades Neuromusculares
- Enfermedad crónica
- Atributos de la enfermedad
- Enfermedades autoinmunes
- Enfermedades del sistema inmunológico
- Enfermedades del Sistema Nervioso Periférico
- Enfermedades Autoinmunes del Sistema Nervioso
- Enfermedades desmielinizantes
- Polineuropatías
- Condiciones Patológicas, Signos y Síntomas
- Polirradiculoneuropatía Crónica Inflamatoria Desmielinizante
- Polirradiculoneuropatía
- Síndorme de Guillain-Barré
- Polirradiculopatía
Otros números de identificación del estudio
Otros números de identificación del estudio
- 110SL24
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Marco de tiempo para compartir IPD
2024/10/01
Criterios de acceso compartido de IPD
on resonable request to the study' PI
Tipo de información de apoyo para compartir IPD
- PROTOCOLO DE ESTUDIO
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .